Kalergis David G 4
4 · Diffusion Pharmaceuticals Inc. · Filed Jan 4, 2018
Insider Transaction Report
Form 4
Kalergis David G
DirectorChairman and CEO
Transactions
- Award
Stock Option (Right to Buy)
2018-01-02+55,000→ 55,000 totalExercise: $1.18Exp: 2028-01-02→ Common Stock (55,000 underlying)
Footnotes (1)
- [F1]The shares underlying the options vest in 36 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a three-year period beginning on January 31, 2018.